Home / Diabetes In Control (page 8)

Diabetes In Control

Tirzepatide: A Dual GLP-1/GIP Receptor Agonist for the Treatment of T2D

Authors: Ashley Wagnild, PharmD Candidate 2024, Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University A 54-year-old man was referred to the pharmacotherapy clinic by his primary care provider (PCP) for a therapy consult. The patient had a past medical …

Read More »

Bromocriptine-QR Therapy and its Impact on the Pro-inflammatory State of Type 2 Diabetes Subjects in Relation to CVD

Sponsored Content  Bromocriptine-QR (Cycloset) “is a sympatholytic dopamine D2 agonist for the treatment of type 2 diabetes that has demonstrated rapid (within 1 year) substantial reductions in adverse cardiovascular events in this population by as yet incompletely delineated mechanisms.” This study investigated the impact of Cycloset on the pro-inflammatory state …

Read More »

Could Dapagliflozin Be Beneficial in The Treatment of Patients with Type 2 Diabetes and Multiple Risk Factors

What are the effects of prescribing sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and multiple risk factors? Type 2 diabetes (T2D) usually occurs with multiple risk factors and complications. When treating patients with T2D targeting several risk factors, especially in the early stages of the disease state, …

Read More »

Hormone Therapy: Does it Lead to Increased Incidence of Diabetes in Trans Men and Women?

Studies have found that there may be a connection between hormone therapy use and type 2 diabetes, putting transgender individuals at an increased risk.   Transgender individuals commonly use hormone therapy to generate the person’s desired physical characteristics. In addition to transforming the individuals’ physical characteristics, hormone therapy can also alter …

Read More »

Blaming the COVID-19 Pandemic for Weight Gain

The current COVID-19 Pandemic may be to blame for weight gain in patients at a higher risk of developing diabetes. The Healthier You: NHS Diabetes Prevention Program (NHS DPP) developed by the National Health Service (NHS) in 2016 was created to delay or avert the emergence of type 2 diabetes …

Read More »